The aim of this study was to compare the perinatal outcomes of pregnancies with intermittently absent end-diastolic umbilical artery Doppler flow and persistently absent flow, focusing on their implications for clinical management. This retrospective cohort study was conducted at Basaksehir Cam and Sakura City Hospital between 2020 and 2023, and included 137 pregnancies diagnosed with either intermittently absent end-diastolic umbilical artery Doppler flow (n=38) or persistently absent flow (n=99). Demographic data, pregnancy complications, delivery details, and neonatal outcomes were analyzed. The mean latency from diagnosis to delivery was statistically significantly longer in the intermittently absent end-diastolic umbilical artery Doppler flow group (15.6 days) than in the persistently absent flow group (7.88 days; p<0.0001). The intermittently absent end-diastolic umbilical artery Doppler flow group demonstrated better outcomes, with a higher gestational age at delivery and improved Apgar scores. Notably, although the difference was not statistically significant, all stillbirths (n=4) occurred in the persistently absent flow group. No intergroup differences were found in terms of intensive care unit admission or neonatal intubation. This study highlights an important prognostic distinction between intermittently absent end-diastolic umbilical artery Doppler flow and persistently absent flow, with intermittently absent end-diastolic umbilical artery Doppler flow representing a less severe form of placental insufficiency. These findings provide valuable insights for optimizing antenatal surveillance strategies, suggesting that intermittently absent end-diastolic umbilical artery Doppler flow cases may be candidates for outpatient management, whereas persistently absent flow cases require more intensive monitoring.

Background: Maternal thyroid hormones play an essential role in fetal growth and pregnancy maintenance. While thyroid dysfunction earlier in pregnancy has been widely studied, the clinical relevance of thyroid function assessed at the time of labor admission remains unclear. This study aimed to evaluate the association between maternal thyroid function parameters measured at labor ward admission and obstetric and neonatal outcomes in term pregnancies. Methods: This retrospective observational study included 664 women with singleton term pregnancies (≥37 weeks) admitted to the labor ward of a tertiary referral center between May 2020 and May 2025. Maternal thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels were measured at admission. Obstetric outcomes included gestational age at delivery and mode of delivery, while neonatal outcomes comprised birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission. Univariable analyses and multivariable logistic and ordinal regression models adjusted for key obstetric confounders were performed. Results: Gestational age at delivery differed significantly across FT4 tertiles, with higher FT4 levels associated with a greater proportion of late-term deliveries (p = 0.018). Lower FT4 levels were independently associated with lower neonatal birth weight categories after adjustment for gestational age and parity (adjusted OR per 1 SD decrease: 1.19; 95% CI: 1.02–1.38; p = 0.025). Although an inverse association between FT4 tertiles and cesarean delivery due to fetal distress was observed in unadjusted analyses, this association was not retained after multivariable adjustment. Maternal TSH levels were not independently associated with obstetric or neonatal outcomes. No significant associations were observed with Apgar scores or NICU admission. Conclusions: In term pregnancies, maternal FT4 levels measured at labor admission are associated with delivery timing and neonatal birth weight but do not independently predict cesarean delivery due to fetal distress or adverse immediate neonatal outcomes.

Background: Maternal thyroid hormones are essential for fetal development and the maintenance of pregnancy. While thyroid dysfunction earlier in gestation has been extensively studied, the clinical relevance of thyroid function assessed at labor admission remains unclear. This study investigated the association between maternal thyroid function parameters measured at labor ward admission and obstetric and neonatal outcomes in term pregnancies. Methods: In this retrospective observational study, 664 women with singleton term pregnancies (≥37 weeks) admitted to the labor ward of a tertiary referral center were included. Maternal thyroid-stimulating hormone (TSH), free thyroxine (FT4), and admission complete blood count parameters (hemoglobin, hematocrit, white blood cell count, and platelet count) were recorded. Obstetric and neonatal outcomes were compared across FT4 tertiles using univariable and multivariable regression analyses adjusted for key obstetric confounders. Results: Gestational age at delivery differed significantly across FT4 tertiles, with higher FT4 levels associated with a greater proportion of late-term deliveries. Lower FT4 levels were independently associated with lower neonatal birth weight categories after adjustment for gestational age and parity. Admission complete blood count parameters did not differ significantly across FT4 tertiles or gestational age categories. Maternal TSH levels were not independently associated with obstetric or neonatal outcomes, and no significant associations were observed with Apgar scores or NICU admission. Conclusions: In term pregnancies, maternal FT4 levels measured at labor admission are associated with delivery timing and neonatal birth weight but do not independently predict intrapartum fetal distress or adverse immediate neonatal outcomes.

Chronicpelvic pain is a multifactorial condition that significantly impacts women’s quality of life. Pelvic venous disorders (PeVD) are increasingly

Purpose: Surgical-site infections (SSI) remain a major complication of cesarean delivery, increasing maternal morbidity, hospital stay, and healthcare costs. Although several risk factors have been identified, the role of maternal nutritional status—particularly the Prognostic Nutritional Index (PNI)—has not been well established in obstetric surgery. Methods: This retrospective case–control study included 190 women who underwent cesarean delivery at a tertiary referral center between 2020 and 2025. Preoperative PNI was calculated using serum albumin and lymphocyte counts obtained within 24 h before surgery. SSI was defined according to the Centers for Disease Control and Prevention criteria. Demographic, perioperative, and postoperative variables were analyzed to evaluate associations between PNI, SSI status, infection severity, and inflammatory markers. Results: A total of 190 women were analyzed, including 98 cases with surgical-site infection (SSI) and 92 controls without SSI. Although preoperative PNI was not an independent predictor of SSI, lower PNI values were associated with more severe infections requiring broad-spectrum antibiotics, longer hospitalization, and higher postoperative C-reactive protein (CRP) levels. A significant inverse correlation was observed between PNI and CRP among patients with SSI ( r = − 0.338, p = 0.001). Longer operative duration and smoking were also associated with an increased risk of SSI. Conclusion: Although PNI was not an independent predictor of SSI, lower values were strongly associated with infection severity and systemic inflammation. Integrating PNI into preoperative risk assessment—alongside body mass index and operative time—may help identify high-risk women. Larger prospective studies are warranted to confirm these findings and to evaluate the impact of nutritional optimization on postoperative outcomes.